| Geralyn Doskoch, MD | |
|
14705 W Upright St, Charlevoix, MI 49720-1949 | |
| (231) 547-6520 | |
| (231) 547-5404 |
| Full Name | Geralyn Doskoch |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 14705 W Upright St, Charlevoix, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710079256 | NPI | - | NPPES |
| 381459366062 | Other | MI | COMMUNITY CHOICE PIN# |
| 4301065473 | Other | MI | BC LICENSE NUMBER |
| GD065473 | Other | MI | BLUE SHIELD LICENSE NUM |
| 4847260 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 4301065473 (Michigan) | Secondary |
| 207Q00000X | Family Medicine | 4301065473 (Michigan) | Primary |
| Entity Name | Munson Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083761860 PECOS PAC ID: 3072426287 Enrollment ID: O20040108000904 |
News Archive
Research from the University of Cincinnati College of Medicine suggests that the 60 percent greater incidence of prostate cancer among African-American men is related to a gene mutation developed generations ago in West Africa as nature's way of providing protection from the malaria infection endemic in that part of the world.
Two medications approved as treatment for drug-resistant chronic myeloid leukemia continue to provide patients with quicker, better responses as a first treatment than the existing front-line drug, researchers at The University of Texas M. D. Anderson Cancer Center reported at the 51st Annual Meeting of the American Society of Hematology.
Maxim Pharmaceuticals has announced the results of an international Phase 3 clinical trial testing the combination of Ceplene (TM) plus interleukin-2 (IL-2) in 320 patients with acute myeloid leukemia (AML) in complete remission.
Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Tuesday published Issue 208 of its "Global Fund Observer." Among others, the issue contains two stories on the new funding model (NFM), which, according to the first article, the Global Fund to Fight AIDS, Tuberculosis and Malaria expects to launch by the end of February.
While the effects of acute stroke have been widely studied, brain damage during the subacute phase of stroke has been a neglected area of research. Now, a new study by the University of South Florida reports that within a week of a stroke caused by a blood clot in one side of the brain, the opposite side of the brain shows signs of microvascular injury.
› Verified 9 days ago
| Entity Name | Munson Healthcare Charlevoix Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629154307 PECOS PAC ID: 4284528035 Enrollment ID: O20071011000237 |
News Archive
Research from the University of Cincinnati College of Medicine suggests that the 60 percent greater incidence of prostate cancer among African-American men is related to a gene mutation developed generations ago in West Africa as nature's way of providing protection from the malaria infection endemic in that part of the world.
Two medications approved as treatment for drug-resistant chronic myeloid leukemia continue to provide patients with quicker, better responses as a first treatment than the existing front-line drug, researchers at The University of Texas M. D. Anderson Cancer Center reported at the 51st Annual Meeting of the American Society of Hematology.
Maxim Pharmaceuticals has announced the results of an international Phase 3 clinical trial testing the combination of Ceplene (TM) plus interleukin-2 (IL-2) in 320 patients with acute myeloid leukemia (AML) in complete remission.
Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Tuesday published Issue 208 of its "Global Fund Observer." Among others, the issue contains two stories on the new funding model (NFM), which, according to the first article, the Global Fund to Fight AIDS, Tuberculosis and Malaria expects to launch by the end of February.
While the effects of acute stroke have been widely studied, brain damage during the subacute phase of stroke has been a neglected area of research. Now, a new study by the University of South Florida reports that within a week of a stroke caused by a blood clot in one side of the brain, the opposite side of the brain shows signs of microvascular injury.
› Verified 9 days ago
| Entity Name | Hospitalist Medicine Physicians Of Michigan Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013180181 PECOS PAC ID: 4486703170 Enrollment ID: O20090529000290 |
News Archive
Research from the University of Cincinnati College of Medicine suggests that the 60 percent greater incidence of prostate cancer among African-American men is related to a gene mutation developed generations ago in West Africa as nature's way of providing protection from the malaria infection endemic in that part of the world.
Two medications approved as treatment for drug-resistant chronic myeloid leukemia continue to provide patients with quicker, better responses as a first treatment than the existing front-line drug, researchers at The University of Texas M. D. Anderson Cancer Center reported at the 51st Annual Meeting of the American Society of Hematology.
Maxim Pharmaceuticals has announced the results of an international Phase 3 clinical trial testing the combination of Ceplene (TM) plus interleukin-2 (IL-2) in 320 patients with acute myeloid leukemia (AML) in complete remission.
Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Tuesday published Issue 208 of its "Global Fund Observer." Among others, the issue contains two stories on the new funding model (NFM), which, according to the first article, the Global Fund to Fight AIDS, Tuberculosis and Malaria expects to launch by the end of February.
While the effects of acute stroke have been widely studied, brain damage during the subacute phase of stroke has been a neglected area of research. Now, a new study by the University of South Florida reports that within a week of a stroke caused by a blood clot in one side of the brain, the opposite side of the brain shows signs of microvascular injury.
› Verified 9 days ago
| Entity Name | Sound Inpatient Physicians-michigan Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639311996 PECOS PAC ID: 5395896849 Enrollment ID: O20090624000252 |
News Archive
Research from the University of Cincinnati College of Medicine suggests that the 60 percent greater incidence of prostate cancer among African-American men is related to a gene mutation developed generations ago in West Africa as nature's way of providing protection from the malaria infection endemic in that part of the world.
Two medications approved as treatment for drug-resistant chronic myeloid leukemia continue to provide patients with quicker, better responses as a first treatment than the existing front-line drug, researchers at The University of Texas M. D. Anderson Cancer Center reported at the 51st Annual Meeting of the American Society of Hematology.
Maxim Pharmaceuticals has announced the results of an international Phase 3 clinical trial testing the combination of Ceplene (TM) plus interleukin-2 (IL-2) in 320 patients with acute myeloid leukemia (AML) in complete remission.
Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Tuesday published Issue 208 of its "Global Fund Observer." Among others, the issue contains two stories on the new funding model (NFM), which, according to the first article, the Global Fund to Fight AIDS, Tuberculosis and Malaria expects to launch by the end of February.
While the effects of acute stroke have been widely studied, brain damage during the subacute phase of stroke has been a neglected area of research. Now, a new study by the University of South Florida reports that within a week of a stroke caused by a blood clot in one side of the brain, the opposite side of the brain shows signs of microvascular injury.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Geralyn Doskoch, MD 14705 W Upright St, Charlevoix, MI 49720-1949 Ph: (231) 547-6519 | Geralyn Doskoch, MD 14705 W Upright St, Charlevoix, MI 49720-1949 Ph: (231) 547-6520 |
News Archive
Research from the University of Cincinnati College of Medicine suggests that the 60 percent greater incidence of prostate cancer among African-American men is related to a gene mutation developed generations ago in West Africa as nature's way of providing protection from the malaria infection endemic in that part of the world.
Two medications approved as treatment for drug-resistant chronic myeloid leukemia continue to provide patients with quicker, better responses as a first treatment than the existing front-line drug, researchers at The University of Texas M. D. Anderson Cancer Center reported at the 51st Annual Meeting of the American Society of Hematology.
Maxim Pharmaceuticals has announced the results of an international Phase 3 clinical trial testing the combination of Ceplene (TM) plus interleukin-2 (IL-2) in 320 patients with acute myeloid leukemia (AML) in complete remission.
Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Tuesday published Issue 208 of its "Global Fund Observer." Among others, the issue contains two stories on the new funding model (NFM), which, according to the first article, the Global Fund to Fight AIDS, Tuberculosis and Malaria expects to launch by the end of February.
While the effects of acute stroke have been widely studied, brain damage during the subacute phase of stroke has been a neglected area of research. Now, a new study by the University of South Florida reports that within a week of a stroke caused by a blood clot in one side of the brain, the opposite side of the brain shows signs of microvascular injury.
› Verified 9 days ago
Chris Loewen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 14734 Park Ave, Charlevoix, MI 49720 Phone: 231-547-6554 Fax: 231-547-5404 | |
Dr. Daniel M Mann, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 14734 Park Ave, Charlevoix, MI 49720 Phone: 231-547-6554 Fax: 231-547-1179 | |
Anna G Young, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 14705 W Upright St, Charlevoix, MI 49720 Phone: 231-547-8777 Fax: 231-547-8638 | |
Darcie Jean Sharapova, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 14734 Park Ave, Charlevoix, MI 49720 Phone: 231-547-6554 Fax: 231-392-7332 | |
Dr. Melodie R Brown, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 14705 W Upright St, Charlevoix, MI 49720 Phone: 231-547-1308 Fax: 231-392-7332 | |
Dr. Nathan Craig Boss, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 14700 Lake Shore Dr, Charlevoix, MI 49720 Phone: 231-547-3124 Fax: 231-547-8916 | |
Dr. Edward E Newcomb, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 14705 W Upright St, Charlevoix, MI 49720 Phone: 231-547-1308 Fax: 231-392-7332 |